Loading clinical trials...
Loading clinical trials...
This study seeks to evaluate the safety and efficacy of Nelotanserin for the treatment of Rapid Eye Movement (REM) Sleep Behavior Disorder (RBD) in subjects with dementia with Lewy bodies (DLB) or Par...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Axovant Sciences Ltd.
NCT05471960 · REM Sleep Behavior Disorder
NCT05721911 · Parkinson Disease, REM Sleep Behavior Disorder
NCT04246437 · Autonomic Failure, Pure Autonomic Failure, and more
NCT06441864 · Nightmare, Nightmare Disorder With Associated Other Sleep Disorder, and more
NCT07284290 · Dementia With Lewy Bodies, Parkinson Disease Dementia, and more
US120
Birmingham, Alabama
US164
Phoenix, Arizona
US145
Sun City, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions